Mild behavioral impairment as a potential marker of predementia risk states in motor neuron diseases.

Pilar M FerraroEster GervinoEmiliano De MariaGiuseppe MeoMarta Ponzano Matteo Pardini Alessio SignoriAngelo SchenoneLuca Roccatagliata Claudia Caponnetto

Published in: European journal of neurology (2022)

MBI represents a valuable clinical marker of incident cognitive decline in MNDs, and its evaluation has good potential for detecting dementia in its preclinical/prodromal phase.

Keyphrases

cognitive decline
mild cognitive impairment
cardiovascular disease
human health
parkinson disease
cognitive impairment
type diabetes
bone marrow